Background Rapid detection of tuberculosis (TB) among people living with human
immunodeficiency virus (HIV) is a global health priority. HIV‐associated TB may have …

Background The lateral flow urine lipoarabinomannan (LF‐LAM) assay Alere Determine™
TB LAM Ag is recommended by the World Health Organization (WHO) to help detect active …

Background New diagnostic tools are urgently needed to interrupt the transmission of
tuberculosis and multidrug-resistant tuberculosis. Rapid, sensitive detection of tuberculosis …

Detection of Mycobacterium tuberculosis antigens in urine is attractive as a potential means
of diagnosing tuberculosis (TB) regardless of the anatomical site of disease. The most …

Tuberculosis (TB) is a major threat to global health, recently exacerbated by the emergence
of highly drug-resistant forms of the disease-causing pathogen and synergy with HIV/AIDS …

Although the human immunodeficiency virus (HIV) infection pandemic has had a
catastrophic impact on tuberculosis (TB) control efforts, especially in sub-Saharan Africa …

Background The global tuberculosis epidemic results in nearly 2 million deaths and 9 million
new cases of the disease a year. The vast majority of tuberculosis patients live in develo** …

Objective: To assess the utility of urine lipoarabinomannan (LAM) detection as a diagnostic
screening test for tuberculosis (TB) in HIV-infected patients with advanced …

Background The accurate diagnosis of TB in HIV-infected patients, particularly with
advanced immunosuppression, is difficult. Recent studies indicate that a lipoarabinomannan …

A direct antigen-capture ELISA based on the detection of mycobacterial lipoarabinomannan
(LAM) in unprocessed urine was evaluated for its usefulness in clinical practice. In Tanzania …